naltrexone has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, ZP; Rutka, JT; Sun, HS; Turlova, E; Wong, R | 1 |
| Kast, RE | 1 |
1 review(s) available for naltrexone and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma.
Topics: Brain Neoplasms; Central Nervous System Stimulants; Drug Approval; Drug Synergism; Glioblastoma; Humans; Methamphetamine; Naltrexone; Narcotic Antagonists; Neovascularization, Pathologic; Quaternary Ammonium Compounds; United States; United States Food and Drug Administration; Vascular Endothelial Growth Factor A | 2009 |
1 other study(ies) available for naltrexone and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Activation of TRPM7 by naltriben enhances migration and invasion of glioblastoma cells.
Topics: Brain Neoplasms; Calcium; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glioblastoma; Humans; Immunoblotting; Matrix Metalloproteinase 2; Membrane Potentials; Naltrexone; Neoplasm Invasiveness; Patch-Clamp Techniques; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TRPM Cation Channels | 2017 |